2022 article

What can we learn from treating atopic itch in dogs?

Labib, A., Yosipovitch, G., & Olivry, T. (2022, August). JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Vol. 150, pp. 284–286.

By: A. Labib, G. Yosipovitch & T. Olivry

author keywords: Atopic dermatitis; eczema; dog; pruritus; itch; JAK inhibitor; IL-31 inhibitor; oclacitinib; lokivetmab
Source: Web Of Science
Added: December 5, 2022

Atopic dermatitis (AD) is a common, chronic skin disorder affecting up to 2.4% of the worldwide population. It negatively affects patients and their caregivers owing to the unrelenting itch, rash, and disturbed sleep. Not only does AD affect humans, but it is also very prevalent in domestic canines. Because of the extensive similarities in the phenotype and pathogenesis between human and canine AD, the latter serves as an excellent model to evaluate the use of novel antipruritic drugs.